As per our Trefis Valuation methodology, CVS Health (NYSE:CVS) stock is worth $62, which is about 15% higher than the current market price. Our Price Estimate is based on a P/E multiple of 10.84 and an earnings estimate of $5.80 for FY 2019. The company had a mixed FY 2018 wherein they posted a ...
As per our Trefis Valuation methodology, CVS Health (NYSE:CVS) stock is worth $62, which is about 15% higher than the current market price. Our Price Estimate is based on a P/E multiple of 10.84 and an earnings estimate of $5.80 for FY 2019. The company had a mixed FY 2018 wherein they posted a ...
Share this Article
Recommended